Penserra Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-41,296
| Closed | -$4.08M | – | 1207 |
|
|
2024
Q3 | $4.08M | Sell |
41,296
-1,521
| -4% | -$150K | 0.09% | 213 |
|
|
2024
Q2 | $3.97M | Buy |
+42,817
| New | +$3.97M | 0.05% | 263 |
|
|
2020
Q3 | – | Sell |
-3,616
| Closed | -$404K | – | 1045 |
|
|
2020
Q2 | $404K | Buy |
+3,616
| New | +$404K | 0.02% | 388 |
|
|
2018
Q2 | – | Sell |
-18,109
| Closed | -$1.59M | – | 613 |
|
|
2018
Q1 | $1.59M | Buy |
+18,109
| New | +$1.59M | 0.15% | 106 |
|